IPO Boutique

Nightstar Therapeutics Limited IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Nightstar Therapeutics Limited, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Nightstar Therapeutics LimitedNITE -
NASDAQ
$13.00-$15.00 $14.00 $17.255.36 million ADSs9/28/2017
Jefferies, Leerink Partners, BMO Capital Markets
Co-Manager(s):
Wedbush PacGrow, Chardan
Health Care
Filing(s):

Filed 2017-08-31
Terms Added 2017-09-15



Nightstar Therapeutics Limited Quote & Chart - Click for current quote - NITE

About Nightstar Therapeutics Limited (adapted from Nightstar Therapeutics Limited prospectus):
They are a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "NITE" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved